Whalegun
New listings

Aktis OncologyAKTS

ListedNasdaq

Road to listing

  1. Filed (S-1)25/12/19
  2. 2 amendments01/07
    Last amendment
  3. Declared effective01/08
  4. Priced01/08
  5. Listed01/09
  6. Lock-up ends07/08
    Passed

Offering terms

Offer price
$18.00
Shares offered
17,650,000 sh
Raised
$317.7M
Exchange
Nasdaq
Lock-up
180 days · prospectus
Aktis Oncology stock pagePrice and every trade

5% holders

Form
MPM Bioventures 2018
19.3%10,260,064 sh13D01/20
Lilly & Co Eli
11.9%6,344,114 sh13D01/15
VV Manager II
10.9%5,831,315 sh13D01/14
EcoR1 Capital
9.1%4,862,335 sh13D01/20
Blue Owl Capital Holdings
5.9%3,161,348 sh13G passive05/14

5 planned sale notices (Form 144) by this company's insiders

Filings

  • 424B4 final prospectus01/09
  • EFFECT notice of effectiveness01/08
  • 8-A12B exchange registration01/07
  • S-1/A amendment01/07
  • S-1/A amendment01/05
  • S-1 registration statement25/12/19